🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00268905
Treatments Being Tested
This is a phase II, multicenter, open-label, randomized controlled trial to...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2024-10-01
Trial ID
NCT06102824
This study is a Phase I/II study evaluating the safety and effectiveness of...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2022-03-09
Trial ID
NCT04711824
Treatments Being Tested
This study is being done to see how safe the combination of eribulin and ca...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2013-02-06
Trial ID
NCT01795586
Treatments Being Tested
A Single-Center Retrospective Study About Efficacy and Safety of Eribulin-B...
Status
Unknown
Location
Fujian Cancer Hospital
Start Date
2023-02-01
Trial ID
NCT05953909
Treatments Being Tested
This study will evaluate the safety and efficacy of eribulin in combination...
Status
Terminated
Location
Holy Cross Hospital
Start Date
2011-08
Trial ID
NCT01388647
Treatments Being Tested
This is a phase II clinical trial of the combination of carboplatin, eribul...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-09-30
Trial ID
NCT03032614
Treatments Being Tested